Anshuman Dixit
Title
Cited by
Cited by
Year
2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action
A Geronikaki, P Eleftheriou, P Vicini, I Alam, A Dixit, AK Saxena
Journal of medicinal chemistry 51 (17), 5221-5228, 2008
1162008
Elucidation of the Hsp90 C-terminal inhibitor binding site
RL Matts, A Dixit, LB Peterson, L Sun, S Voruganti, P Kalyanaraman, ...
ACS chemical biology 6 (8), 800-807, 2011
972011
A systematic protocol for the characterization of Hsp90 modulators
RL Matts, GEL Brandt, Y Lu, A Dixit, M Mollapour, S Wang, AC Donnelly, ...
Bioorganic & medicinal chemistry 19 (1), 684-692, 2011
822011
Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations
A Dixit, GM Verkhivker
PLoS computational biology 5 (8), e1000487, 2009
782009
Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases
A Dixit, GM Verkhivker
PLoS computational biology 7 (10), e1002179, 2011
772011
Sequence and structure signatures of cancer mutation hotspots in protein kinases
A Dixit, L Yi, R Gowthaman, A Torkamani, NJ Schork, GM Verkhivker
PloS one 4 (10), e7485, 2009
772009
Design of combretastatin A-4 analogs as tubulin targeted vascular disrupting agent with special emphasis on their cis-restricted isomers
H Rajak, P Kumar Dewangan, V Patel, D Kumar Jain, A Singh, ...
Current pharmaceutical design 19 (10), 1923-1955, 2013
742013
Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design
P Misra, T Khaliq, A Dixit, S SenGupta, M Samant, S Kumari, A Kumar, ...
Journal of antimicrobial chemotherapy 62 (5), 998-1002, 2008
592008
An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis
KK Roy, A Dixit, AK Saxena
Journal of Molecular Graphics and Modelling 27 (2), 197-208, 2008
562008
Exquisite Selectivity for Human Toll-Like Receptor 8 in Substituted Furo[2,3-c]quinolines
HP Kokatla, D Sil, SS Malladi, R Balakrishna, AR Hermanson, LM Fox, ...
Journal of medicinal chemistry 56 (17), 6871-6885, 2013
522013
Probing molecular mechanisms of the Hsp90 chaperone: Biophysical modeling identifies key regulators of functional dynamics
A Dixit, GM Verkhivker
PloS one 7 (5), e37605, 2012
522012
Anoxic–aerobic SBR system for nitrate, phosphate and COD removal from high-strength wastewater and diversity study of microbial communities
J Jena, R Kumar, M Saifuddin, A Dixit, T Das
Biochemical Engineering Journal 105, 80-89, 2016
502016
Computational modeling of structurally conserved cancer mutations in the RET and MET kinases: the impact on protein structure, dynamics, and stability
A Dixit, A Torkamani, NJ Schork, G Verkhivker
Biophysical journal 96 (3), 858-874, 2009
482009
Computer-aided drug design: integration of structure-based and ligand-based approaches in drug design
P Prathipati, A Dixit, AK Saxena
Current Computer-Aided Drug Design 3 (2), 133-148, 2007
472007
ERRβ Signaling Involves FST and BCAS2 for Inhibiting Cellular Proliferation in Breast Cancer Cells
D Sengupta, DK Bhargava, A Dixit, BS Sahoo, S Biswas, G Biswas, SK Mishra
British journal of cancer 110 (8), 2144-2158, 2014
46*2014
Development of CoMFA, advance CoMFA and CoMSIA models in pyrroloquinazolines as thrombin receptor antagonist
A Dixit, SK Kashaw, S Gaur, AK Saxena
Bioorganic & medicinal chemistry 12 (13), 3591-3598, 2004
442004
Ebola virus disease: past, present and future
H Rajak, DK Jain, A Singh, AK Sharma, A Dixit
Asian Pacific Journal of Tropical Biomedicine 5 (5), 337-343, 2015
412015
A structural insight into hydroxamic acid based histone deacetylase inhibitors for the presence of anticancer activity
H Rajak, A Singh, K Raghuwanshi, R Kumar, PK Dewangan, ...
Current medicinal chemistry 21 (23), 2642-2664, 2014
402014
Protein kinase C-theta inhibitors: a novel therapy for inflammatory disorders
S Chand, N Mehta, M Singh Bahia, A Dixit, O Silakari
Current pharmaceutical design 18 (30), 4725-4746, 2012
402012
Human Toll-Like Receptor 8-Selective Agonistic Activities in 1-Alkyl-1H-benzimidazol-2-amines
M Beesu, SS Malladi, LM Fox, CD Jones, A Dixit, SA David
Journal of medicinal chemistry 57 (17), 7325-7341, 2014
382014
The system can't perform the operation now. Try again later.
Articles 1–20